In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Abhinab MohantyDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.ORCID 0009-0000-6524-8005 Myna NakabashiDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
Barbara K M DiasDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
Pedro MaioliniDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
José Antonio Campos DelgadoLaboratory for Sustainable Organic Synthesis and Catalysis, Department of Chemistry, Federal University of São Carlos-UFSCar, São Carlos, São Paulo, Brazil.ORCID 0000-0002-5994-7384 Karina de Souza QuaglioLaboratory for Sustainable Organic Synthesis and Catalysis, Department of Chemistry, Federal University of São Carlos-UFSCar, São Carlos, São Paulo, Brazil.ORCID 0000-0002-4415-949X Márcio Weber PaixãoLaboratory for Sustainable Organic Synthesis and Catalysis, Department of Chemistry, Federal University of São Carlos-UFSCar, São Carlos, São Paulo, Brazil.
Celia R S GarciaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0003-2825-1701 Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico 304638/2023-4Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.896791/2023-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/15522-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/07656-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/09115-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2025/04088-7
6 · The paper itselfAbstract
Malaria remains a persistent global health challenge, and emerging resistance to artemisinin-based therapy threatens disease control. Here, we report the evaluation of scaffolds selected from three classes of indole hybrids. A library of 24 synthetically designed indoles was screened
Indexed as
AntimalarialsEthanolaminesFluorenesIndolesPlasmodium falciparumDrug SynergismHEK293 CellsHumansLumefantrineParasitic Sensitivity TestsAntimalarialsEthanolaminesFluorenesIndolesLumefantrineantimalarialscombination therapygametocyteindole derivativesPlasmodium falciparum
Identifiers
PMID42383988
PMCPMC13436391
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390